PINNACLE ASSOCIATES LTD
Q4 2023 13F-HR Holdings
Net value change ($000)
+563,604
(10.5%)
New positions
40
Sold out positions
33
Turnover %
1.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q3 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| MSFT | 32,527 | 20.7% |
| AAPL | 28,036 | 12.2% |
| AVGO | 19,588 | 32.6% |
| CYTK | 13,930 | 182.3% |
| ImmunoGen, Inc. | 13,874 | 86.0% |
| AMZN | 12,522 | 19.6% |
| RCL | 12,088 | 35.9% |
| JPM | 11,956 | 17.2% |
| XYL | 11,084 | 23.8% |
| VB | 9,366 | 12.8% |
Top Reduces (Value $000, Stocks/ETFs)
| Seagen Inc. | -32,341 | -100.0% |
| BMY | -10,170 | -42.7% |
| PLUG | -8,934 | -42.6% |
| VIAV | -8,813 | -96.7% |
| VSH | -6,036 | -21.3% |
| PFE | -5,070 | -18.3% |
| ARRY | -4,466 | -24.4% |
| THRY | -4,015 | -74.5% |
| XOM | -3,863 | -15.4% |
| INTERCEPT PHARMACEUTICALS, INC. | -3,657 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|